Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Population Genetics Technologies Ltd.
DescriptionHCV drug resistance diagnostic test targeting six HCV genotypes using VeriTag next generation sequencing technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPilot
Standard IndicationInfectious, Diagnostic
Indication DetailsDiagnose drug resistance to hepatitis C virus (HCV) therapeutics in patients with HCV
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today